Should metabolic diseases be systematically screened in nonsyndromic autism spectrum disorders?
<h4>Background</h4>In the investigation of autism spectrum disorders (ASD), a genetic cause is found in approximately 10-20%. Among these cases, the prevalence of the rare inherited metabolic disorders (IMD) is unknown and poorly evaluated. An IMD responsible for ASD is usually identifie...
Guardado en:
Autores principales: | Manuel Schiff, Jean-François Benoist, Sofiane Aïssaoui, Odile Boespflug-Tanguy, Marie-Christine Mouren, Hélène Ogier de Baulny, Richard Delorme |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1611c12f2bfa4000b6c5823b18e6e055 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Diagnostic contribution of metabolic workup for neonatal inherited metabolic disorders in the absence of expanded newborn screening
por: Alexandra Bower, et al.
Publicado: (2019) -
Identification of pathway-biased and deleterious melatonin receptor mutants in autism spectrum disorders and in the general population.
por: Pauline Chaste, et al.
Publicado: (2010) -
Astroglia in Autism Spectrum Disorder
por: Kinga Gzielo, et al.
Publicado: (2021) -
The pathogenesis of autism spectrum disorder
por: Beatriz Sanabria-Barradas, et al.
Publicado: (2021) -
Olfactory functions are not associated with autism severity in autism spectrum disorders
por: Dudova I, et al.
Publicado: (2013)